Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
3
×
detroit blog main
detroit top stories
gene therapy
gilead sciences
glaxosmithkline
3
×
immunotherapy
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biogen
clinical trials
cystic fibrosis
deals
diagnostics
What
bio
roundup
drug
abbvie’s
acquisitions
ahead
albert
approval
biggest
biofourmis
biogen’s
biopharmaceutical
bourla
bucks
cancer
celebrate
ceo
chance
companies
company
convo
corner
crispr
day
days
earlier
failures
forward
future
holiday
imports
labor
littered
looking
maker
maps
measured
nash
new
news
Language
unknown
unset
Current search:
glaxosmithkline
×
abbvie
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More